Ntrk Fusion-positive Solid Tumors
📧 Sign up to get email alerts when something new happens for Ntrk Fusion-positive Solid Tumors.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-06-11FDA Approved: IBTROZI — Original Application (Nuvation Bio Inc.)
FDA approved IBTROZI (taletrectinib) in an original NDA for NTRK fusion‑positive solid tumors, providing a tumor‑agnostic treatment option.